506
Views
2
CrossRef citations to date
0
Altmetric
Review

Obstructive sleep apnea and cardiovascular events in elderly patients

ORCID Icon &
Pages 197-210 | Received 28 Jul 2021, Accepted 10 Jan 2022, Published online: 25 Jan 2022

References

  • Jiménez JFM, Illa F, Gil FC, et al. Resources and delays in the diagnosis of sleep apnea-hypopnea syndrome. Arch Bronconeumol. 2007;43(4):188–198.
  • MÁ M-G, Durán-Cantolla J, JM M. El síndrome de apneas-hipopneas durante el sueño en edades avanzadas. Arch Bronconeumol. 2010 Sep 1;46(9):479–488.
  • Munoz R, Duran-Cantolla J, Martínez-Vila E, et al. Severe sleep apnea and risk of ischemic stroke in the elderly. Stroke. 2006 Sep;37(9):2317–2321.
  • Martínez-García M-A, Campos-Rodríguez F, Catalán-Serra P, et al. Cardiovascular mortality in obstructive sleep apnea in the elderly: role of long-term continuous positive airway pressure treatment a prospective observational study. Am J Respir Crit Care Med. 2012;186:909–916.
  • Ancoli-Israel S, Kripke D, Klauber M, et al. Mortality and sleep-disordered breathing in community dwelling elderly. Sleep. 1996;19(4):277–282. [Internet]
  • Catalan-Serra P, Campos-Rodriguez F, Reyes-Nuñez N, et al. Increased incidence of stroke, but not coronary heart disease, in elderly patients with sleep apnea. Stroke. 2019;50(2):491–494.
  • Heinzer R, Vat S, Marques-Vidal P, et al. Prevalence of sleep-disordered breathing in the general population: the HypnoLaus study. Physiol Behav. 2015;3(4):310–318.
  • Ancoli-Israel S, Kripke DF, Klauber MR, et al. Sleep-disordered breathing in community-dwelling elderly. Sleep. 1991 [cited 2021 Nov 2];14(6):486.
  • American academy of sleep medicine international classification of sleep disorders. 3rd ed. Darien: IL American Academy of Sleep Medicine; 2014.
  • Menzin J, Park S. Excess costs associated with obstructive sleep apnea in the elderly. Value Heal. 2016;19(7):A352.
  • Han TS, Tajar A, Lean MEJ. Obesity and weight management in the elderly. Br Med Bull. 2011;97(1):169–196.
  • Wang S, Niu X, Zhang P, et al. Analysis of OSAS incidence and influential factors in middle-aged and elderly patients with hypertension. Minerva Med. 2019 Apr 1;110(2):115–120.
  • Guest JF, Helter MT, Morga A, et al. Cost-effectiveness of using continuous positive airway pressure in the treatment of severe obstructive Sleep apnoea/hypopnoea syndrome in the UK. Thorax. 2008;63(10):860–865.
  • Ayas NT, FitzGerald JM, Fleetham JA, et al. Cost-effectiveness of continuous positive airway pressure therapy for moderate to severe obstructive sleep apnea/hypopnea. Arch Intern Med. 2006;166(9):977–984.
  • Tempaku PF, Mazzotti DR, Hirotsu C, et al. The effect of the severity of obstructive sleep apnea syndrome on telomere length. Oncotarget. 2016;7(43):69216.
  • Leal J, Luengo-Fernández R, Gray A, et al. Economic burden of cardiovascular diseases in the enlarged European Union. Eur Heart J. 2006;27(13):1610–1619.
  • Yazdanyar ANA. The burden of cardiovascular disease in the elderly: morbidity, mortality, and costs. Clin Geriatr Med. 2009;25(4):253–258.
  • Marin JM, Carrizo SJ, Vicente EAA. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet. 2005;365:1046–1053.
  • Arzt M, Young T, Finn L, et al. Association of sleep-disordered breathing and the occurrence of stroke. Am J Respir Crit Care Med. 2005;172:1447–1451. [Internet]
  • Gottlieb DJ, Yenokyan G, Newman AB, et al. A prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure: the sleep heart health study. Circulation. 2010;122:352–360.
  • Redline S, Yenokyan G, Gottlieb DJ, et al. Obstructive sleep apnea-hypopnea and incident stroke the sleep heart health study. Am J Respir Crit Care Med. 2010;182:269–277.
  • Campos-Rodriguez F, MA M-G, De La Cruz-Moron I, et al. Cardiovascular mortality in women with obstructive sleep apnea with or without continuous positive airway pressure treatment a cohort study. Ann Intern Med. 2012;156:115–122.
  • Young T, Shahar E, Nieto FJ, et al. Predictors of sleep-disordered breathing in community-dwelling adults: the sleep heart health study. Arch Intern Med. 2002 Apr 22;162(8):893–900.
  • Punjabi NM, Caffo BS, Goodwin JL, et al. Sleep-disordered breathing and mortality: a prospective cohort study. PLoS Med. 2009;6:e1000132.
  • DL B, NG B, AM P, et al. Sleep apnea and mortality in an aged cohort. Am J Public Heal. 1988;78:544–547.
  • Marin JM, Soriano JB, Carrizo SJ, et al. Outcomes in patients with chronic obstructive pulmonary disease and obstructive sleep apnea: the overlap syndrome. Am J Respir Crit Care Med. 2010;182(3):325–331.
  • Lavie P, Lavie L, Herer P. All-cause mortality in males with sleep apnoea syndrome: declining mortality rates with age. Eur Respir J. 2005;25(3):514–520.
  • Lavie L, Lavie P. Ischemic preconditioning as a possible explanation for the age decline relative mortality in sleep apnea. Med Hypotheses. 2006;66(6):1069–1073.
  • Lavie P, Lavie L. Unexpected survival advantage in elderly people with moderate sleep apnoea. J Sleep Res. 2009 Dec 1;18(4):397–403. cited 2020 May 12.
  • Phillips BA, Berry DTR, Lipke-Molby TC. Sleep-disordered breathing in healthy, aged persons: fifth and final year follow-up. Chest. 1996;110(3):654–658.
  • Enright PL, Newman AB, Wahl PW, et al. Prevalence and correlates of snoring and observed apneas in 5,201 older adults. Sleep. 1996;19(7):531–538.
  • Haas DC, Foster GL, Nieto FJ, et al. Age-dependent associations between sleep-disordered breathing and hypertension: importance of discriminating between systolic/diastolic hypertension and isolated systolic hypertension in the sleep heart health study. Circulation. 2005;111(5):614–621.
  • Maniaci A, Iannella G, Cocuzza S, et al. Oxidative stress and inflammation biomarker expression in obstructive sleep apnea patients. J Clin Med. 2021 Jan 13;10(2):277.
  • Somers VK, Dyken ME, and Mark ALAF. Sympathetic-nerve activity during sleep in normal subjects N Engl J Med.1993;328:303–307.
  • Somers VK, Dyken ME, Clary MP, et al. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest. 1995;96(4):1897–1904.
  • Bradley TD, Floras JS. Obstructive sleep apnoea and its cardiovascular consequences. Lancet. 2009 Jan 3;373(9657):82–93.
  • Narkiewicz K, Pjh VDB, Cooley RL, et al. Sympathetic activity in obese subjects with and without obstructive sleep apnea. Circulation. 1998 Aug 25;98(8):772–776. cited 2020 May 10.
  • Narkiewicz K, Montano N, Cogliati C, et al. Altered cardiovascular variability in obstructive sleep apnea. Circulation. 1998 Sep 15;98(11):1071–1077.
  • Singh JP, Larson MG, Tsuji H, et al. Reduced heart rate variability and new-onset hypertension. Hypertension. 1998 Aug;32(2):293–297. cited 2020 May 10.
  • Guidelines, American TN. Guidelines. guidelines heart rate variability. Eur Heart J. 1996;17:354–381.
  • Gjørup PH, Sadauskiene L, Wessels J, et al. Abnormally increased endothelin-1 in plasma during the night in obstructive sleep apnea: relation to blood pressure and severity of disease. Am J Hypertens. 2007;20:44–52.
  • Vgontzas AN, Papanicolaou DA, and Bixler EO, et al. Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity J Clin Endocrinol Metab. 1997;82. 1313–1316.
  • Ryan S, Taylor CT, McNicholas WT. Predictors of elevated nuclear factor-κB-dependent genes in obstructive sleep apnea syndrome. Am J Respir Crit Care Med. 2006;174(7):824–830.
  • Ohga E, Tomita T, Wada H, et al. Effects of obstructive sleep apnea on circulating ICAM-1, IL-8, and MCP-1. J Appl Physiol. 2003 [cited 2020 May 10];94:179–184.
  • Shamsuzzaman ASM, Winnicki M, and Lanfranchi P, et al. Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation. 2002 May 28;105(21):2462–2464.
  • Dyugovskaya L, and Lavie PLL. Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am J Respir Crit Care Med. 2002;165(7):934–939.
  • Yj S, Jain V, A-m P, et al. Oxidative stress and oxidant signaling in obstructive sleep apnea and associated cardiovascular diseases. Free Radic Biol Med. 2006;40:1683–1692.
  • Hoffmann MS, Singh P, Wolk R, et al. Microarray studies of genomic oxidative stress and cell cycle responses in obstructive sleep apnea. Redox Signal. 2007;9:661–669.
  • Phillips BG, Narkiewicz K, Pesek CA, et al. Effects of obstructive sleep apnea on endothelin-1 and blood pressure. J Hypertens. 1999;17:61–66.
  • Ip MSM, Tse H-F, Lam B, et al. endothelial function in obstructive sleep apnea and response to treatment. Am J Respir Crit Care Med. 2004;169:348–353.
  • Buda AJ, Pinsky MR, Ingels NB Jr, et al. Effect of intrathoracic pressure on left ventricular performance. N Engl J Med. 1979;301:453–459.
  • Somers VK, and Dyken MESJ. Autonomic and hemodynamic responses and interactions during the Mueller maneuver in humans J Auton Nerv Syst. 1993;44:253–259.
  • Romero-Corral A, Somers VK, Pellikka PA, et al. Decreased right and left ventricular myocardial performance in obstructive sleep apnea. Chest. 2007;132:1863–1870.
  • Beelke M, Angeli S, Del Sette M, et al. Prevalence of patent foramen ovale in subjects with obstructive sleep apnea: a transcranial Doppler ultrasound study. Sleep Med. 2003;4(3):219–223.
  • Mansukhani MP, Kara T, Caples S, et al. Chemoreflexes, sleep apnea, and sympathetic dysregulation. Curr Hypertens Rep. 2014 Sep 1;16(9):476.
  • Spiegel K, Knutson K, Leproult R, et al. Sleep loss: a novel risk factor for insulin resistance and type 2 diabetes. J Appl Physiol. 2005;99:2008–2019. [Internet]
  • Punjabi NM, Shahar E, and Redline S, et al. Sleep-disordered breathing, glucose intolerance, and insulin resistance the sleep heart health study Am J Epidemiol. 2004;160(6):521–530. .;():.:
  • Harsch IA, Schahin SP, Brückner K, et al. The effect of continuous positive airway pressure treatment on insulin sensitivity in patients with obstructive sleep apnoea syndrome and type 2 diabetes. Respiration. 2004;71:252–259.
  • Von Känel R, Loredo JS, and Ancoli-Israel S, et al. Asociation between polysomnographic measures of disrupted sleep and prothrombotic factors. Chest. 2007;131(3):733–739.
  • Liak C, Fitzpatrick M, and Dabsm F. Coagulability in obstructive sleep apnea. Can Respir J. 2011;18(6):338.
  • Ge X, Han F, Huang Y, et al. Is obstructive sleep apnea associated with cardiovascular and all-cause mortality? PLoS One. 2013;8(7):e69432.
  • MÁ M-G, Soler-Cataluña JJ, Ejarque-Martínez L, et al. Continuous positive airway pressure treatment reduces mortality in patients with ischemic stroke and obstructive sleep apnea: a 5-year follow-up study. Am J Respir Crit Care Med. 2009;180(1):36–41.
  • Shah NA, Klar Yaggi H, Concato J, et al. Obstructive sleep apnea as a risk factor for coronary events or cardiovascular death. Sleep Breath. 2010;14:131–136.
  • Yeboah J, Redline S, and Johnson C, et al. Association between sleep apnea, snoring, incident cardiovascular events and all-cause mortality in an adult population: MESA. Atherosclerosis. 2011;219. 963–968.
  • Mehra R, Stone KL, Varosy PD, et al. Nocturnal arrhythmias across a spectrum of obstructive and central sleep-disordered breathing in older men: outcomes of sleep disorders in older men (mros sleep) study. Arch Intern Med. 2009;169:1147–1155.
  • Endeshaw YW, White WB, and Kutner M, et al. Sleep-disordered breathing and 24-hour blood pressure pattern among older adults. J Gerontol A Biol Sci Med Sci. 2009;64(2):280–285.
  • Lamberts M, Nielsen OW, Lip GYH, et al. Cardiovascular risk in patients with sleep apnoea with or without continuous positive airway pressure therapy: follow-up of 4.5 million Danish adults. J Intern Med. 2014 Dec 1;276(6):659–666.
  • Campos-Rodriguez F, Martinez-Garcia MA, and Reyes-Nuñez N, et al. Role of sleep apnea and continuous positive airway pressure therapy in the incidence of stroke or coronary heart disease in women Am J Respir Crit Care Med. 2014;189(12): 1544–50 .
  • Tsapanou A, Gu Y, O’Shea D, et al. Self-reported sleep disordered breathing as risk factor for mortality in the elderly. J Stroke Cerebrovasc Dis. 2016 Jun 1;25(6):1524–1531.
  • Gooneratne NS, Richards KC, Joffe M, et al. Sleep disordered breathing with excessive daytime sleepiness is a risk factor for mortality in older adults. Sleep. 2011;34(4):435–442.
  • López-Padilla D, Alonso-Moralejo R, Martínez-García MÁ, et al. Continuous positive airway pressure and survival of very elderly persons with moderate to severe obstructive sleep apnea. Sleep Med. 2016;19:23–29.
  • Ou Q, Chen YC, Zhuo SQ, et al. Continuous positive airway pressure treatment reduces mortality in elderly patients with moderate to severe obstructive severe sleep apnea: a cohort study. PLoS One. 2015 Jun 11;10(6):e0127775.
  • Nishihata Y, Takata Y, Usui Y, et al. Continuous positive airway pressure treatment improves cardiovascular outcomes in elderly patients with cardiovascular disease and obstructive sleep apnea. Heart Vessels. 2015 Dec 8;30(1):61–69.
  • Narkiewicz K, Kato M, Phillips BG, et al. Nocturnal continuous positive airway pressure decreases daytime sympathetic traffic in obstructive sleep apnea. Circulation. 1999 Dec 7;100(23):2332–2335.
  • Seif F, Patel SR, Walia HK, et al. Obstructive sleep apnea and diurnal nondipping hemodynamic indices in patients at increased cardiovascular risk. J Hypertens. 2014;32(2):267–275.
  • Peppard PE, Young T, Palta M, et al. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med. 2000 May 11;342(19):1378–1384.
  • Cano-Pumarega I, Durán-Cantolla J, Aizpuru F, et al. Obstructive sleep apnea and systemic hypertension - Longitudinal study in the general population: the vitoria sleep cohort. Am J Respir Crit Care Med. 2011 Dec 1;184(11):1299–1304.
  • Roche F, Pépin JL, Achour-Crawford E, et al. At 68 years, unrecognised sleep apnoea is associated with elevated ambulatory blood pressure. Eur Respir J. 2012 Sep 1;40(3):649–656.
  • Guillot M, Sforza E, Achour-Crawford E, et al. Association between severe obstructive sleep apnea and incident arterial hypertension in the older people population. Sleep Med. 2013 Sep 1;14(9):838–842.
  • EO B, AN V, HM L, et al. Association of hypertension and sleep-disordered breathing. Arch Intern Med. 2000 Aug 14;160(15):2289–2295.
  • Pepperell JCT, Ramdassingh-Dow S, Crosthwaite N, et al. Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet. 2002 Jan 19;359(9302):204–210.
  • Montesi SB, Edwards BA, Malhotra A, et al. Effect of continuous positive airway pressure treatment on blood pressure: a systematic review and meta-analysis of randomized controlled trials. J Clin Sleep Med. 2012;8:587–596.
  • Pépin JL, Tamisier R, Barone-Rochette G, et al. Comparison of continuous positive airway pressure and valsartan in hypertensive patients with sleep apnea. Am J Respir Crit Care Med. 2010 Oct 1;182(7):954–960.
  • Campos-Rodriguez F, Grilo-Reina A, Perez-Ronchel J, et al. Effect of continuous positive airway pressure on ambulatory BP in patients with sleep apnea and hypertension: a placebo-controlled trial. Chest. 2006;129(6):1459–1467.
  • Barbé F, LR M, Duran J, et al. Treatment with continuous positive airway pressure is not effective in patients with sleep apnea but no daytime sleepiness: a randomized, controlled trial. Ann Intern Med. 2001 Jun 5;134(11):1015–1023.
  • Kohler M, Pepperell JCT, Casadei B, et al. CPAP and measures of cardiovascular risk in males with OSAS. Eur Respir J. 2008;32(6):1488–1496.
  • McMillan A, Bratton DJ, Faria R, et al. Continuous positive airway pressure in older people with obstructive sleep apnoea syndrome (PREDICT): a 12-month, multicentre, randomised trial. Lancet Respir Med. 2014 Oct 1;2(10):804–812.
  • MÁ M-G, Chiner E, Hernández L, et al. Obstructive sleep apnoea in the elderly: role of continuous positive airway pressure treatment. Eur Respir J. 2015 Jul 1;46(1):142–151.
  • Ponce S, Pastor E, and Orosa B, et al. The role of CPAP treatment in elderly patients with moderate obstructive sleep apnoea: a multicentre randomised controlled trial. Eur Respir J. 2019 ;54(1900518).
  • Mehra R, Benjamin EJ, Shahar E, et al. Association of nocturnal arrhythmias with sleep-disordered breathing the sleep heart health study. Am J Respir Crit Care Med. 2006;173:910–916.
  • Gami AS, Pressman G, Caples SM, et al. Association of atrial fibrillation and obstructive sleep apnea. Circulation. 2004 Jul 27;110(4):364–367.
  • Gami AS, Friedman PA, Chung MK, et al. Therapy insight: interactions between atrial fibrillation and obstructive sleep apnea. Nat Clin Pract Cardiovasc Med. 2005;2:145–149.
  • Punjabi NM. The epidemiology of adult obstructive sleep apnea. Proc Am Thorac Soc. 2008;5:136–143.
  • Todd K, McIntyre WF, Baranchuk A. Obstructive sleep apnea and atrial fibrillation. Nat Sci Sleep. 2010;2:39–45.
  • Miller JD, Aronis KN, Chrispin J, et al. Obesity, exercise, obstructive sleep apnea, and modifiable atherosclerotic cardiovascular disease risk factors in atrial fibrillation. J Am Coll Cardiol. 2015;66:2899–2906. Elsevier USA
  • Monahan K, Storfer-Isser A, Mehra R, et al. Triggering of nocturnal arrhythmias by sleep-disordered breathing events. J Am Coll Cardiol. 2009 Nov 3;54(19):1797–1804.
  • Anzai T, Grandinetti A, Katz AR, et al. Cross-ethnic comparison of the association between central sleep apnea and atrial fibrillation/flutter: the kuakini honolulu-asia aging study and the osteoporotic fractures in men (mr.os) study. IJC Hear Vasc. 2021 Aug;1(35):100834.
  • Kwon Y, Picel K, Adabag S, et al. Sleep-disordered breathing and daytime cardiac conduction abnormalities on 12-lead electrocardiogram in community-dwelling older men. Sleep Breath. 2016 Dec 1;20(4):1161–1168.
  • May A, Blackwell T, Stone P, et al. Central sleep-disordered breathing predicts incident atrial fibrillation in older men. Am J Respir Crit Care Med. 2016 Apr 1;193(7):783–791.
  • Fein AS, Shvilkin A, Shah D, et al. Treatment of obstructive sleep apnea reduces the risk of atrial fibrillation recurrence after catheter ablation. J Am Coll Cardiol. 2013 Jul 23;62(4):300–305.
  • Holmqvist F, Guan N, Zhu Z, et al. Impact of obstructive sleep apnea and continuous positive airway pressure therapy on outcomes in patients with atrial fibrillation—results from the outcomes registry for better informed treatment of atrial fibrillation (ORBIT-AF). Am Heart J. 2015 May 1;169(5):647–654.e2.
  • Deng F, Raza A, Guo J. Treating obstructive sleep apnea with continuous positive airway pressure reduces risk of recurrent atrial fibrillation after catheter ablation: a meta-analysis. Sleep Med. 2018 Jun;46(46):5–11.
  • Simantirakis EN, Schiza, SI, Marketou, ME, et al. Severe bradyarrhythmias in patients with sleep apnoea: the effect of continuous positive airway pressure treatmentA long-term evaluation using an insertable loop recorder. Eur Heart J. 2004;25(12):1070–1076.
  • Kanagala R, Murali NS, Friedman PA, et al. Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation. 2003 May 27;107(20):2589–2594.
  • Anter E, Zimetbaum P, Josephson M. Treatment of obstructive sleep apnea reduces the risk of atrial fibrillation recurrence following catheter ablation. Am Coll Cardiol. 2012;59(13):612.
  • Bitter T, Horstkotte D, Oldenburg O. Disclosures: sleep disordered breathing and the pathogenesis of atrial fibrillation. J Cardiovasc Electrophysiol. 2012;23(1):18–25.
  • Eysenck W, Sulke N, Freemantle N. W E, N S, N F, NR P, SS F, RA V. The effect of atrial fibrillation intervention on nocturnal respiratory events in elderly patients with persistent AF. Clin Respir J.2019 May 1;13(5):280–288.
  • Piccini JP, Pokorney SD, Anstrom KJ, et al. Adaptive servo-ventilation reduces atrial fibrillation burden in patients with heart failure and sleep apnea. Hear Rhythm. 2019 Jan 1;16(1):91–97.
  • Behrouz R, Malek AR, Torbey MT. Small vessel cerebrovascular disease: the past, present, and future. Stroke Res Treat. 2012;2012:839151.
  • Johnson KG, Johnson DC. Frequency of sleep apnea in stroke and TIA patients: a meta-analysis. J Clin Sleep Med. 2010 Apr 15;6(2):131–137.
  • Hudgel DW, Lamerato LE, Jacobsen GR. DCL. Assessment of multiple health risks in a single obstructive sleep apnea population. J Clin Sleep Med. 2012;8(1):9–18.
  • Shahar E, Whitney CW, Redline S, et al. Sleep-disordered breathing and cardiovascular disease cross-sectional results of the sleep heart health study. Am J Respir Crit Care Med. 2001;163(1):19–25.
  • Sahlin C, Sandberg O, Gustafson Y, et al. Obstructive sleep apnea is a risk factor for death in patients with stroke: a 10-year follow-up. Arch Intern Med. 2008 Feb 11;168(3):297–301.
  • Foster GE, Hanly PJ, Ostrowski M, et al. Effects of continuous positive airway pressure on cerebral vascular response to hypoxia in patients with obstructive sleep apnea. Am J Respir Crit Care Med. 2007;175(7):720–725.
  • Wessendorf T, Wang Y, Thilmann A, et al. Treatment of obstructive sleep apnoea with nasal continuous positive airway pressure in stroke. Eur Respir J. 2001;18(4):623–629.
  • Mitchell ARJ, Spurrell PAR, Sulke N. Circadian variation of arrhythmia onset patterns in patients with persistent atrial fibrillation. Am Hear J. 2003;146:902–907.
  • MA M-G, Campos-Rodríguez F, Soler-Cataluña J-J, et al. Increased incidence of nonfatal cardiovascular events in stroke patients with sleep apnoea: effect of CPAP treatment. Eur Respir J. 2012 Apr 1;39(4):906–912.
  • Parra O, Á S-A, Capote F, et al. Efficacy of continuous positive airway pressure treatment on 5-year survival in patients with ischaemic stroke and obstructive sleep apnea: a randomized controlled trial. J Sleep Res. 2015 Feb 1;24(1):47–53.
  • Wegener S, Gottschalk B, Jovanovic V, et al. Transient Ischemic Attacks Before Ischemic Stroke: preconditioning the Human Brain? Stroke. 2004 Mar;35(3):616–621.
  • Bernaudin M, Nedelec A-S, Divoux D, et al. Normobaric hypoxia induces tolerance to focal permanent cerebral ischemia in association with an increased expression of hypoxia-inducible factor-1 and its target genes, erythropoietin and vegf, in the adult mouse brain. J Cereb Blood Flow Metab. 2002;22(4):393–403.
  • Stone KL, Blackwell TL, Ancoli-Israel S, et al. Sleep disordered breathing and risk of stroke in older community-dwelling men. Sleep. 2016 Mar 1;39(3):531.
  • Holt A, Bjerre J, Zareini B, et al. Sleep apnea, the risk of developing heart failure, and potential benefits of continuous positive airway pressure (cpap) therapy. J Am Heart Assoc. 2018 Jul 3 [cited 2020 May 31];7(13):e008684.
  • Uchôa CHG, Pedrosa RP, Javaheri S, et al. OSA and prognosis after acute cardiogenic pulmonary edema: the osa-care study. Chest. 2017 Dec 1;152(6):1230–1238.
  • Hla KM, Young T, Hagen EW, et al. Coronary heart disease incidence in sleep disordered breathing: the wisconsin sleep cohort study. Sleep. 2015 May 1;38(5):677–684.
  • Kasai TBT,Bradley TD. Obstructive sleep apnea and heart failure: pathophysiologic and therapeutic implications. J Am Coll Cardiol. 2011;57(2):119–127.
  • Chami HA, Resnick HE, Quan SF, et al. The association of incident cardiovascular disease with progression of sleep-disordered breathing. Circulation. 2011;123(12):1280–1286.
  • Laaban J-P, Pascal-Sebaoun S, Bloch E, et al. Left ventricular systolic dysfunction in patients with obstructive sleep apnea syndrome*. Chest. 2002;122(4):1133–1138.
  • Dursunoglu N, Dursunoglu D, Özkurt S, et al. Effects of CPAP on right ventricular myocardial performance index in obstructive sleep apnea patients without hypertension. Respir Res. 2006;7(1):22.
  • Mansfield DR, Gollogly NC, Kaye DM, et al. Controlled trial of continuous positive airway pressure in obstructive sleep apnea and heart failure. Am J Respir Crit Care Med. 2004;169(3):361–366.
  • Sforza E, Sabri M, DaCosta A, et al. Echocardiographic findings in healthy elderly people with unrecognized sleep disordered breathing. Journal of Clinical Sleep Medicine. 2015 Sep 15;11(9):975–980.
  • Roca GQ, Redline S, Claggett B, et al. Sex-Specific association of sleep apnea severity with subclinical myocardial injury, ventricular hypertrophy, and heart failure risk in a community-dwelling cohort. Circulation. 2015;132(14):1329–1337.
  • Javaheri S, Blackwell T, Ancoli-Israel S, et al. Sleep-disordered breathing and incident heart failure in older men. Am J Respir Crit Care Med. 2016 Mar 1;193(5):561–568.
  • Martinez D, Klein C, Rahmeier L, et al. Sleep apnea is a stronger predictor for coronary heart disease than traditional risk factors. Sleep Breath. 2012;3:695–701.
  • Peker Y, Carlson J, Hedner J. Increased incidence of coronary artery disease in sleep apnoea: a long-term follow-up. Eur Respir J. 2006;28:596–602.
  • Kim T, Lee C, Lee S, et al. Impacts of comorbidities on the association between arterial stiffness and obstructive sleep apnea in the elderly. Respiration. 2015;89:304–311.
  • Liu Y, Downey JM. Ischemic preconditioning protects against infarction in rat heart. Am J Physiol. 1992;263:1107–1112.
  • Yellon DM, Alkhulaifi AMPW. Preconditioning the human myocardium. Lancet. 1993;342:276–277.
  • Pang CY, Yang RZ, Zhong A, et al. Acute ischaemic preconditioning protects against skeletal muscle infarction in the pig. Cardiovasc Res. 1995;29:782–788.
  • Moore-Olufemi SD, Kozar RA, Moore FA, et al. Ischemic preconditioning protects against gut dysfunction and mucosal injury after ischemia/ reperfusion injury. Shock. 2005;23:258–263.
  • Ng SSS, Chan T-O, To K-W, et al. Prevalence of obstructive sleep apnea syndrome and CPAP adherence in the elderly chinese population. PLoS One. 2015 Mar 16;10(3):e0119829.
  • Sánchez-de-la-torre M, Sánchez-de-la-torre A, Bertran S, et al. Effect of obstructive sleep apnoea and its treatment with continuous positive airway pressure on the prevalence of cardiovascular events in patients with acute coronary syndrome (ISAACC study): a randomised controlled trial. Lancet Respir Med. 2020 Apr 1;8(4):359–367.
  • Haentjens P, Van Meerhaeghe A, Moscariello A, et al. The impact of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea syndrome: evidence from a meta-analysis of placebo-controlled randomized trials. Arch Intern Med. 2007 Apr 23;167(8):757–765.
  • Bazzano LA, Khan Z, Reynolds K, et al. Effect of nocturnal nasal continuous positive airway pressure on blood pressure in obstructive sleep apnea. Hypertension. 2007 Aug;50(2):417–423.
  • Barbé F, Durán-Cantolla J, Capote F, et al. Long-term effect of continuous positive airway pressure in hypertensive patients with sleep apnea. Am J Respir Crit Care Med. 2010;181:718–726.
  • Barbé F, Durán-Cantolla J, Sánchez-De-La-Torre M, et al. Effect of continuous positive airway pressure on the incidence of hypertension and cardiovascular events in nonsleepy patients with obstructive sleep apnea: a randomized controlled trial. J Am Med Assoc. 2012 May 23;307(20):2161–2168. * Randomized controlled trial that showed a reduction on the incidence of Hypertension or cardiovascular events in OSA patients treated with CPAP.
  • Peker Y, Balcan B. Cardiovascular outcomes of continuous positive airway pressure therapy for obstructive sleep apnea. J Thorac Dis. 2018;10(S34):S4262–79.
  • Parra O, Sánchez-Armengol Á, Bonnin M, et al. Early treatment of obstructive apnoea and stroke outcome: a randomised controlled trial. Eur Respir J. 2011 May 1;37(5):1128–1136. * Randomized controlled trial that failed to show any appreciable effect of CPAP treatment on cardiovascular event. * Randomized controlled trial that failed to show any appreciable effect of CPAP treatment on cardiovascular eventfree survival in OSA patients with stroke.
  • RD M, NA A, Heeley E, et al. CPAP for prevention of cardiovascular events in obstructive sleep apnea. N Engl J Med. 2016;375(10):919–931.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.